1. Medtech Insight
  2. >>Geography
  3. >>North America
  4. >>Canada

MDx Health Signs Exclusive Canadian Agreement

 
• By Catherine Longworth

MDx Health has signed an exclusive distribution deal to make its liquid biopsy prostate cancer test available in Canada.

Handshake - Hand holding on Canada flag background - Image

MDxHealth SA has signed an exclusive distribution agreement with Canadian lab-testing company LifeLabs to make its SelectMDx prostate cancer test available in Canada, the companies announced Feb. 14.

Under the terms of the partnership, LifeLabs will serve as an exclusive distributor for SelectMDx in Canada, liquid biopsy samples will be tested in MDxHealth's California laboratory and LifeLabs will...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Canada

More from North America

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.